Skip to main content
Clinical Trials/ACTRN12615000668505
ACTRN12615000668505
Completed
Not Applicable

Is intracytoplasmic morphologically selected sperm injection (IMSI) more effective than intracytoplasmic sperm injection (ISCI) in cases of severe oligo-astheno-teratozoospermia? A prospective study regarding pregnancy outcome

alexandria university, faculty of medicne0 sites1,729 target enrollmentJune 26, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
male factor infertility and IMSI
Sponsor
alexandria university, faculty of medicne
Enrollment
1729
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
alexandria university, faculty of medicne

Eligibility Criteria

Inclusion Criteria

  • very poor semen quality characterized by severe oligo\-astheno\-teratozoospermia (sperm concentration less than 5 million per ml, less than 50% motile sperms according to WHO criteria and less than 14% morphologically normal spermatozoa according to the Strict Kruger Criteria), a normal karyotype in both partners

Exclusion Criteria

  • Uterine defects, hydrosalpinx, endometriosis, polycystic ovaries, evidence of low ovarian response in previous treatment cycles (less than four oocytes retrieved), infections, endocrinal problems, coagulation defects or thrombophilia and autoimmune defects (including antiphospholipid antibodies) were all excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials